Timothy H. Self, PharmD

Chronic Kidney Disease
Chronic Kidney Disease
Minimizing Risk of Mental Status Changes with H2 Blockers: Dosage Adjustments in Kidney Dysfunction
12/12/2014
Jerry P. Gilless, MD; Joanna Q. Hudson, PharmD, BCPS; Timothy H. Self, PharmD
For the past 35 years, histamine2 blockers (H2 blockers) have continued to have widespread use within the United States. Soon after cimetidine was released, central nervous system (CNS) reactions were...
12/12/2014
Phenytoin Drug Interactions
Phenytoin Drug Interactions
Effects of Other Drugs on Phenytoin
04/30/2011
Christopher K. Finch, PharmD, BCPS; Timothy H. Self, PharmD; Darius L. Mason, PharmD
<div id="article-content-body"><p>Phenytoin is one of the most commonly prescribed antiepileptic drugs in both acute and chronic settings; its use has been extensively described....
04/30/2011
Pitfalls In Prescribing
Pitfalls In Prescribing
Minimizing the Risk of Tendon Injury Associated With Fluoroquinolone Use
09/05/2017
Sami A. Sakaan, PharmD, BCPS; Timothy H. Self, PharmD
The risks of fluoroquinolone use vs the benefits should be assessed for all other indications.
09/05/2017
Warfarin
Warfarin
Topical Miconazole and Increased Response to Warfarin: A Drug Interaction Easily Missed
06/13/2014
Timothy H. Self, PharmD; Andrea S. Franks, PharmD, BCPS
The purpose of this brief review is to focus on these interactions and to urge clinicians to be vigilant regarding patients who use topical miconazole with warfarin.
06/13/2014
Nitrofurantoin Pulmonary Toxicity
Nitrofurantoin Pulmonary Toxicity
Nitrofurantoin Pulmonary Toxicity: A Rare but Serious Complication
04/27/2011
Jennifer Twilla, PharmD, BCPS; John Winton, MD; Timothy H. Self, PharmD
<p>Nitrofurantoin has been widely used for the treatment and prevention of recurrent urinary tract infections since its introduction into clinical practice in 1953.<sup>1,2</sup> Although...
04/27/2011
Psychiatry
Psychiatry
Concomitant Lithium and ACEIs: Increase the Index of Suspicion for Lithium Toxicity
03/15/2017
Benjamin T. Duhart, Jr., MS, PharmD; Timothy H. Self, PharmD
A high index of suspicion for lithium toxicity is necessary when it is taken concomitantly with ACEIs.
03/15/2017
lung disease
lung disease
Amiodarone-Induced Lung Disease
03/13/2014
Shanise J. Patterson, PharmD, BCPS; Carrie S. Oliphant, PharmD, BCPS; Timothy H. Self, PharmD
The purpose of this brief summary is to focus attention on amiodarone-induced lung disease so that clinicians will be vigilant in monitoring for this serious and potentially fatal adverse drug reaction. ...
03/13/2014
Levothyroxine
Levothyroxine
Drug Interactions That Decrease Levothyroxine Efficacy
04/27/2011
Lori B. Arnold, PharmD; Timothy H. Self, PharmD; Lauren M. Czosnowski, PharmD
<p>Levothyroxine is one of the most commonly prescribed medications for the treatment of hypothyroidism as well as the suppression of thyroid neoplasms.<sup>1</sup> Most patients with...
04/27/2011
Pitfalls In Prescribing
Pitfalls In Prescribing
The Potential Effect of Marijuana and Tobacco on Warfarin Metabolism and INR
12/05/2016
Timothy H. Self, PharmD; Samarth P. Shah, PharmD
A patient’s response to warfarin is affected by several factors such as the use of other drugs, disease states, age, dietary vitamin K, and genetic poymorphisms.
12/05/2016
Anticoagulant
Anticoagulant
Drug Interactions with Novel Oral Anticoagulants
12/17/2013
Kerry Mohrien, PharmD, BCPS; Timothy H. Self, PharmD; Carrie S. Oliphant, PharmD, BCPS
This review will highlight clinically significant drug interactions amongst the NOACs—dabigatran, rivaroxaban, and apixaban—to provide strategies for managing these interactions.
12/17/2013